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Conclusion: STEMI patients with a CTO in a non IRA have an increased mortality,
regardless of the coronary location.
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Background: The aim of this study is to compare the safety and efficacy of Sirolimus
(SES), Paclitaxel (PES), Zotarolimus (ZES-R/ Endeavor Resolute), BiolimusA9 (BES),
EPC capture (ECS) and Everolimus-eluting stent (EES) on the outcome of patients
with chronic total occlusion (CTO).
Methods: A prospective analysis of 1576 patients with 1738 CTOs (396 SES, 526
PES, 219 ZES-R, 209 BES, 148 ECS, 240 EES) in six high volume Asian centers after
successful recanalization of CTO was performed. The study endpoints were 30 days
and 12 months major adverse cardiac events (MACE), 12 months angiographic
restenosis and target lesion revascularization (TLR).
Results: See table for clinical results.
Conclusion: The use of drug-eluting stents in patients with CTO was safe with low
acute complication. Patients treated with 2nd generation DES such as ZES-R, BES
and EES showed lesser rate of restenosis compared with 1st generation drug-eluting
stents.
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Background: There is a paucity of data on long-term clinical outcomes of patients
with insulin dependent diabetes mellitus (IDDM) compared with non-IDDM
undergoing percutaneous coronary intervention (PCI) for chronic total occlusions
(CTO).
Methods: Between 1998 and 2007, a total of 1791 pts with 1852 CTO underwent PCI
at three centers in the US, Italy and South Korea. Time-to-event analyses were
performed using Kaplan-Meier statistics and the log-rank statistic was used to test for
differences between pts with and without DM. Cox regression was used for multivariate
analysis.
Results: A total of 395 (23%) patients had DM, 164 had IDDM (42%) and 231 had
non-IDDM (58%). Procedural success was similar in pts with IDDM and non-IDDM
(68% vs. 71%, p=0.48). After a successful procedure, stents were implanted in 106
patients with IDDM (87% DES) and 159 patients with Non-IDDM (69% DES).Median
follow-up duration was 1080 days. Five-year mortality was significantly increased in
patients with IDDM (23% vs. 7%, p=0.02, figure 1a). After multivariate adjustment,
IDDM remained an independent predictor of mortality (HR 2.25, 95% CI 1.04-4.87,
p=0.04). Other independent predictors were age (HR 1.1, p<0.01) and procedural
success (HR 0.44, p=0.03). Five-year TVR rates after successful PCI were similar in
patients with IDDM and Non-IDDM (24% vs. 27%, p=0.56, figure 1b).
Conclusion: In diabetic patients undergoing CTO PCI, IDDM was an independent
predictor of 5-year mortality. After a successful procedure, TVR rates were similar in
patients with IDDM and non-IDDM.
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Background: Since traditional coronary angiography provides images of the coronary
vessel lumen, chronic total occlusions (CTO) segments are not visible using this
modality. Multislice Computed Tomography (MSCT) provides information on the soft
tissue surrounding the vessel lumen, so it can be used to identify morphological features
such as actual length of the occluded segment, tortuosity and the amount of
calcification. The 3D nature of MSCT allows accurate measurements of length that do
not suffer from calibration limitations and foreshortening. The purpose of this study
was to evaluate the feasibility and operator-perceived added value of advanced software
that provides real time fusion of MSCT images onto the live fluoroscopy during CTO
recanalization.
Methods: In this feasibility study, a software prototype (GE Healthcare, Waukesha,
US) allowing MSCT image fusion with fluoroscopy was used. Manual registration was
performed using anatomical landmarks, such as the vessel ostia and calcifications. This
initial phase of image fusion enabled the operator to plan the procedure. Visualized
portions of the occluded vessel were displayed over the fluoroscopy image in real time,
using ECG gating to match the cardiac phase of the two modalities. The 3D soft tissue
reconstruction of the occluded lumen was displayed on a separate screen allowing real-
time comparison, side by side, between fluoroscopy and MSCT co-registration.
Results: MSCT guided co-registration was performed for a total of 21 CTO
procedures. Real-time registration was successful in all cases and aided in selection of
the view that would provide the least foreshortening and minimal vessel overlapping.
Successful CTO recanalization was achieved in 16 (76%) of the cases. Post-procedural
assessment by the operators ranked the device usefulness as “Very High” in 5 of the
cases, “High” in 9, “Moderate” in 4 and of “Little or No Value” in 3.
Conclusion: This pilot feasibility study demonstrated that MSCT co-registration is
feasible, easily integrated into the standard procedure and is perceived in the majority
of cases as a highly useful tool for CTO recanalization. Further research is warranted
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to determine whether the use of MSCT co-registration will result in improved
procedural success rate.
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Background: Radiation exposure of over 7Gy at International Electric Commission
reference point [Air Kerma (AKR)] increases the risk of radiation injury. Limited data
exist on the predictors of high AKR in complex coronary chronic total occlusion (CTO)
PCI.
Methods: We reviewed the AKR in 310 consecutive CTO recanalization attempts in
303 patients. Radiation exposure was measured during the procedure.
Results: Procedural success was 73.1%. Mean fluoroscopy time was 38.4±21.4min.
Mean radiation was 5.6±3.1Gy and 328±186Gycm2. As compared to successful PCI,
failed attempts were associated with longer fluoroscopy duration (44.6±22.4min vs
36.1±20.6min; p=0.001) and higher radiation (6.2±3.3Gy vs 5.4±3.0Gy; p=0.05).
Patients with AKR above and below 7Gy are compared in the Table. Multivariable
analysis identified body surface area [OR 6.91 (95%CI 1.92, 24.83 p=0.003)], male
gender [OR 2.83 (95%CI 1.00, 8.00 p=0.0495)], calcification [OR 2.49 (95%CI 1.31,
4.71 p=0.005)] and dual injection technique [OR 2.43 (95%CI 1.32, 4.46 p=0.004)] as
independent predictors of AKR >7Gy. There were no statistically significant differences
in AKR according to CTO coronary artery or proximal vs. distal lesions.
Conclusion: Recanalization of complex CTO lesions is associated with high patient
radiation exposure to radiation. Risk factors for increased radiation include large body
surface area, male gender, calcification, and dual injection technique. When these
factors are present, increased vigilance is warranted to employ strategies that reduce
radiation exposure.
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Background: The recanalization of chronic total occlusions (CTOs) in native coronary
arteries no doubt represents one of the most technically challenging of interventional
procedures. Despite recent high success rates owing to the development of new
strategies such as the retrograde approach, complications and their management during
percutaneous coronary intervention (PCI) of CTOs have not been fully evaluated.
Methods: The aim of this study was to investigate in-hospital outcomes, including
complications, with the retrograde approach.
Results: Out of 943 cases involving 1,014 CTOs undergoing attempted recanalization
between 2005 and 2010, 278 cases (29.4%) were attempted using the retrograde
approach. The overall procedural success rate was 85% (862/1,014). CTO lesions were
most frequently located in the right coronary artery (n=166) followed by the left
anterior descending artery (n=80), and the left circumflex artery (n=33). Septal,
epicardial, and saphenous vein graft collaterals were used in 67.3%, 24.8%, and 7.9%
of cases involving the retrograde approach, respectively. Specific complications with
the retrograde approach were observed in 36 cases (14.7%) and were recovered in the
cath-lab with the exception of 1 case as shown in the table.
Conclusion: Although the complication rate during the retrograde approach was
around 15%, all cases were solved with optimal treatments. A safe procedure with
careful wire manipulation and appropriate management should be required for the
retrograde approach.
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Background: Development of a specialized chronic total coronary occlusion (CTO)
revascularization program attentive to procedural guidelines, quality oversight and
cost/resource utilization has not been described.
Methods: A single-center CTO interventional program was initiated requiring: didactic
training, on-site proctorship, determination of case appropriateness, adherence to
procedural safety guidelines and a 2-operator/case approach. Clinical and angiographic
characteristics, procedural outcomes, in-hospital clinical events and cost/resource
utilization were examined.
Results: Among 145 patients, 160 consecutive CTO revascularization procedures were
attempted between October 2009 and December 2010. Procedural and technical
characteristics included: bilateral femoral access, 90.0%; planned retrograde guidewire
placement, 37.5%; re-entry catheter, 10.0%; re-attempt, 10.6%; fluoroscopic time,
67.4±45.5 minutes; contrast volume, 403±215 mL. Average stent number and total
stent length per CTO vessel were 2.6±1.1 and 64.7±30.7, respectively. Overall CTO
success rate was 85.6% (137/160). In-hospital adverse outcomes included: death 0.6%;
emergency bypass surgery, 0.6%; tamponade, 0.6%; myocardial infarction, 1.9%.
Compared with patients undergoing non-CTO PCI, procedural and total hospital costs
per patient were significantly higher among the CTO cohort despite overall similar
contribution margins ($5,173±12,052 CTO vs $5,730±8,958 non-CTO, P=0.58).
Conclusion: Following initiation of a dedicated program with implementation of
quality and performance guidelines, complex CTO revascularization may be safely
performed with outcomes comparable to reports from established centers. Despite
higher resource utilization, CTO revascularization is associated with a positive
contribution margin similar to that of non-CTO procedures. Requirement of educational
and performance standards, mentorship from experts, consensus review for
appropriateness and provision of catheterization laboratory policies may represent a
model for program development.
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In-Stent Restenosis is Not a Benign Clinical Entity, Presenting As Acute
Coronary Syndrome In 40 % Of Cases
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Background: In-stent restenosis (ISR) following stent implantation may occur in 10-
20% of the cases according to patient and lesion complexity. We aimed to determine
the different clinical presentations of ISR in a large cohort of consecutive, non-selected
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